Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Exploristics.

Aiden Flynn1

  • 1Exploristics Ltd, Fourth Floor, 24 Linenhall Street, Belfast, BT2 8BG, UK.

Personalized Medicine
|May 12, 2018
PubMed
Summary
This summary is machine-generated.

Exploristics offers advanced analytics and software for life sciences, enhancing clinical trials and biomarker research. Their new KERUS™ platform optimizes study design for complex data, improving efficiency in biomarker discovery and development.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Peer-Led Cancer Education Intervention in Appalachian Kentucky: Evaluating Effects on Participants' Cancer Knowledge and Perspectives.

Journal of cancer education : the official journal of the American Association for Cancer Education·2025
Same author

Anti-inflammatory therapy with nebulized dornase alfa for severe COVID-19 pneumonia: a randomized unblinded trial.

eLife·2024
Same author

Pulmonary <sup>18</sup>F-FDG uptake helps refine current risk stratification in idiopathic pulmonary fibrosis (IPF).

European journal of nuclear medicine and molecular imaging·2018
Same author

An epithelial biomarker signature for idiopathic pulmonary fibrosis: an analysis from the multicentre PROFILE cohort study.

The Lancet. Respiratory medicine·2017
Same author

Functional capacity, health status, and inflammatory biomarker profile in a cohort of patients with chronic obstructive pulmonary disease.

Journal of cardiopulmonary rehabilitation and prevention·2015
Same author

Longitudinal change in collagen degradation biomarkers in idiopathic pulmonary fibrosis: an analysis from the prospective, multicentre PROFILE study.

The Lancet. Respiratory medicine·2015

Area of Science:

  • Life Sciences Analytics
  • Biostatistics
  • Clinical Trial Optimization

Background:

  • Life sciences research demands robust data analysis for clinical trials, biomarker discovery, and personalized medicine.
  • Existing methods for study design can be inefficient when dealing with complex, correlated data.

Purpose of the Study:

  • To introduce a novel in silico simulation platform for prospective research study optimization.
  • To enhance the efficiency of biomarker discovery and development processes.

Main Methods:

  • Utilizing advanced analytics and specialized software for life sciences.
  • Implementing robust processes and scientific principles for streamlined solutions.
  • Leveraging the KERUS™ platform for in silico simulation and prospective study optimization.
Keywords:
analyticsflexibleinnovationmodelingsimulationsoftwarestatisticsvisualization

Related Experiment Videos

Main Results:

  • The KERUS™ platform offers a user-friendly interface for researchers.
  • The platform enables improved efficiency in handling complex, correlated data.
  • Facilitates enhanced biomarker discovery and development.

Conclusions:

  • The KERUS™ platform represents a significant advancement in optimizing research studies.
  • Provides accessible tools for researchers to improve efficiency and innovation.
  • Supports high-quality statistical modeling, data analysis, and study design.